BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 22521878)

  • 1. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
    Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
    Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
    Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
    J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
    Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
    J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
    Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX
    J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-prandial regulation of hepatic glucokinase and lipogenesis requires the activation of TORC1 signalling in rainbow trout (Oncorhynchus mykiss).
    Dai W; Panserat S; Mennigen JA; Terrier F; Dias K; Seiliez I; Skiba-Cassy S
    J Exp Biol; 2013 Dec; 216(Pt 23):4483-92. PubMed ID: 24031053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.
    Zhang D; Tong X; Arthurs B; Guha A; Rui L; Kamath A; Inoki K; Yin L
    J Biol Chem; 2014 Sep; 289(37):25925-35. PubMed ID: 25063808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c.
    Wan M; Leavens KF; Saleh D; Easton RM; Guertin DA; Peterson TR; Kaestner KH; Sabatini DM; Birnbaum MJ
    Cell Metab; 2011 Oct; 14(4):516-27. PubMed ID: 21982711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
    Sajan MP; Ivey RA; Lee MC; Farese RV
    J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
    Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
    J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
    Guertin DA; Stevens DM; Thoreen CC; Burds AA; Kalaany NY; Moffat J; Brown M; Fitzgerald KJ; Sabatini DM
    Dev Cell; 2006 Dec; 11(6):859-71. PubMed ID: 17141160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.
    Zhang C; Wendel AA; Keogh MR; Harris TE; Chen J; Coleman RA
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1667-72. PubMed ID: 22307628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
    Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
    J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
    Tripathy S; Jump DB
    J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
    Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
    Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.
    Titchenell PM; Quinn WJ; Lu M; Chu Q; Lu W; Li C; Chen H; Monks BR; Chen J; Rabinowitz JD; Birnbaum MJ
    Cell Metab; 2016 Jun; 23(6):1154-1166. PubMed ID: 27238637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells.
    Li S; Oh YT; Yue P; Khuri FR; Sun SY
    Oncogene; 2016 Feb; 35(5):642-50. PubMed ID: 25893295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
    Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
    J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.